BioCentury | Jul 26, 2019
Product Development

Takeda's deals paint a picture of a turnaround in action

...Darzalex daratumumab from Genmab A/S by turbo-charging the compounds with conjugated immunotoxins. Takeda’s internally discovered TAK-079...
...begin Phase I testing in relapsed and/or refractory MM this year. Takeda is also testing TAK-079...
Items per page:
1 - 1 of 1